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Norrin/Frizzled4 (Fz4) signaling activates the canon-
ical Wnt pathway to control retinal vascular develop-
ment. Using genetically engineered mice, we show
that precocious Norrin production leads to prema-
ture retinal vascular invasion and delayed Norrin
production leads to characteristic defects in intrare-
tinal vascular architecture. In genetic mosaics, wild-
type endothelial cells (ECs) instruct neighboring
Fz4/ ECs to produce an architecturally normal
mosaic vasculature, a cell nonautonomous effect.
However, over the ensuing weeks, Fz4/ ECs are
selectively eliminated from the mosaic vasculature,
implying the existence of a quality control program
that targets defective ECs. In the adult retina and
cerebellum, gain or loss of Norrin/Fz4 signaling
results in a cell-autonomous gain or loss, respec-
tively, of blood retina barrier and blood brain barrier
function, indicating an ongoing requirement for Friz-
zled signaling in barrier maintenance and substantial
plasticity in mature CNS vascular structure.
INTRODUCTION
The retinal vasculature has long been an object of scientific
interest due to its central role in ophthalmologic diseases, in-
cluding a variety of inherited disorders of retinal vascularization
(Gariano and Gardner, 2005). Several of these inherited dis-
orders—Norrie disease, osteoporosis-pseudoglioma syndrome,
and familial exudative vitreoretinopathy—have recently been
shown to arise from defects in the genes coding for the ligand
(Norrin), receptor (Frizzled4; Fz4), coreceptor (Lrp5), and chap-
erone (TSPAN12) proteins of a single signaling pathway (abbre-
viated ‘‘Norrin/Fz4’’ signaling) that controls retinal vascular
growth (reviewed in Ye et al., 2010). Norrin is produced by Muller
glia (Ye et al., 2009), and it binds to Fz4 on endothelial cells (ECs),
leading to activation of Lrp5 and the generation of a canonical1332 Cell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc.Wnt signal. In mice carrying targeted mutations in the Norrin/
Fz4 signaling complex, ECs in the developing vasculature fail
to productively invade the early postnatal retina. The result is
an adult retina with only a single layer of vessels on its vitreal
face instead of the normal trilayered arrangement.
Norrin is a highly divergent member of the transforming growth
factor-beta superfamily, with no homology to the Wnt family of
Frizzled ligands. Fz4 appears to be the only receptor for Norrin,
based on the observations that: (1) among the ten mammalian
Frizzled receptors, only Fz4 exhibits high-affinity Norrin binding
(Smallwood et al., 2007) and (2) in mice, the embryonic lethality
caused by ubiquitous Norrin overexpression is completely sup-
pressed by eliminating Fz4 (Ye et al., 2009). Importantly, Fz4
can also bind Wnt ligands and induce canonical signaling in
response to Wnt binding (Junge et al., 2009).
A central role for canonical Wnt signaling in CNS vascular
development has independently emerged from studies of mice
carrying targeted mutations in the genes coding for Wnt7a,
Wnt7b, and beta-catenin (Liebner et al., 2008; Stenman et al.,
2008; Daneman et al., 2009). Without Wnt7a and Wnt7b pro-
duction by the neuroepithelium or beta-catenin expression in
ECs, developing ECs fail to productively invade the embryonic
CNS and do not express proteins characteristic of the blood
brain barrier (BBB). Major unanswered questions regarding
Norrin and Wnt signaling in the vasculature relate to the roles
of this pathway later in life, to the possibility that these roles
may vary in different CNS regions, and to the identification of
the downstream mediators of Norrin- and Wnt-dependent vas-
cular phenotypes.
In the present study, we address a series of questions posed
by the work described in the preceding paragraphs. Are there
specific features of vascular architecture and artery/vein/capil-
lary differentiation that are under the control of Norrin/Fz4
signaling? Are other vascular signaling systems affected by Nor-
rin/Fz4 signaling? Can Norrin/Fz4 signaling be fine-tuned to yield
different vascular architectures? What are the molecules associ-
ated with BBB/blood retina barrier (BRB) differentiation that are
controlled by Norrin/Fz4 signaling? How plastic is the BBB/
BRB phenotype, and, if there is plasticity, is it controlled by Nor-
rin/Fz4 signaling? To address these questions, we have used
Figure 1. Defects in Endothelial Cell Prolif-
eration and Artery-Vein Segregation in
NdpKO Retinas
(A) Vascular cell proliferation at the vitreal surface
measured with EdU labeling at P5, P9, and P15.
Left: WT and NdpKO retina flat-mounts. Right:
quantification of labeled vascular cells as a func-
tion of radial distance from the optic disc. Scale
bar, 100 mm.
(B) Left: flat-mount P10 retinas. Aberrant artery/
vein crossings are seen in NdpKO retinas (arrows).
Right: quantification of crossings for 15 WT and
16 NdpKO retinas at P10 (mean ± SD). Scale
bar, 500 mm.
See also Figures S1 and S2.genetically engineered mice that permit temporal and tissue-
specific control of Norrin/Fz4 signaling. The data reveal both
cell-autonomous and cell-nonautonomous effects, and they
imply a central role for Norrin/Fz4 signaling in CNS vascular
development and in the maintenance of the BBB/BRB state.
RESULTS
Defects in Vascular Architecture and Cell Surface
Vascular Receptors in NdpKO Retinas
In the mouse, the retinal vasculature develops through a series
of stages: first, radial growth at the vitreal face (P1–P9); second,
growth of the deep vascular plexus in the outer plexiform layer
(OPL) (P7–P12); and third, growth of the intermediate vascular
plexus in the inner plexiform layer (IPL) (P11–P17). In the absence
of Norrin/Fz4 signaling, vascular growth across the vitrealCell 151, 1332–1344, Dsurface of the retina is retarded and the
intraretinal capillary network does not
form (Richter et al., 1998; reviewed in Ye
et al., 2010). To further characterize the
consequences of defective Norrin/Fz4
signaling, we quantified the proliferation
of vascular cells at the vitreal surface of
wild-type (WT) versus NdpKO retinas at
P5, P9, and P15 with a 3 hr EdU pulse
label (Figure 1A; Ndp, the gene coding
for Norrin is X-linked; Ndp/Y males and
Ndp/ females will be referred to as
NdpKO). At P5 and P9, EC proliferation
lags in NdpKO compared to WT retinas,
but at P15, NdpKO retinas exhibit an
increase in EC proliferation, presumably
in response to retinal hypoxia.
A second and hitherto unrecognized
defect in retinas lacking Norrin/Fz4 sig-
naling is the frequent crossing of arteries
and veins (Figure 1B and Figure S1 avail-
able online), similar to that seen with loss
of Neuropilin (Nrp)1 and neuron-specific
hemizygous loss of vascular endothelial
growth factor (VEGF)-A (Haigh et al.,
2003; Fantin et al., 2011). In WT retinas,major arteries and veins are segregated into alternating and
radially arrayed territories, and they rarely cross. By contrast,
at P10, NdpKO retinas show an average of four or five crossings
of major arteries and veins and many crossings among smaller
vessels. Additionally, elastin, which normally coats arteries, but
not veins, is present on veins in NdpKO retinas (Figure S2A).
These data suggest that Norrin/Fz4 signaling plays a role in
signaling between arteries and veins or in specifying some
aspects of artery versus vein identity.
The retinal EC phenotypes in the absence of Norrin/Fz4
signaling could reflect, at least in part, a decreased response
to retina-derived proangiogenic factors, such as VEGF, or an
enhanced response to antiangiogenic factors, such as class 3
semaphorins, at least one member of which, Sema3E, regulates
retinal vascular development (Fukushima et al., 2011; Kim et al.,
2011). To test this idea, we localized transcripts coding for VEGF,ecember 7, 2012 ª2012 Elsevier Inc. 1333
Figure 2. Altered Expression of Receptors
that Control Vascular Development in
NdpKO Retinas
(A) At P30, VEGF transcripts accumulate in the
INL in NdpKO retinas and VEGF-R1, VEGF-R2,
Nrp1, and Nrp2 transcripts accumulate in aberrant
EC clusters in the NdpKO retina (arrows). ONL,
outer nuclear layer; INL, inner nuclear layer; GCL,
ganglion cell layer. Scale bars (A and B), 100 mm.
(B) At P30, AP fusion protein ligands reveal
VEGF-A and VEGF-B, but not Sema3F, binding
sites throughout the WT retinal vasculature. In EC
clusters inNdpKO retinas, binding sites are present
for VEGF-A and Sema3F, but not for VEGF-B.
Specificity is demonstrated for the AP-VEGF
ligands by competition with 10 mg/ml VEGF-A.
(C) Summary of published ligand-receptor-binding
specificities (Geretti et al., 2008; Pellet-Many et al.,
2008) and observed patterns of AP-ligand binding
to retinal vasculature (B). VEGF-B(167) binds Nrp1
but VEGF-B(186) does not (Makinen et al., 1999).
The AP-VEGF-B construct used here produces
AP-VEGF-B(186) as the initial translation product;
the extent of its proteolytic conversion to AP-
VEGF-B(167) is unknown.VEGF receptor (VEGFR)1, VEGFR2, and Nrp1 and Nrp2 (which
function as class 3 semaphorin receptors) in mature WT and
NdpKO retinas by in situ hybridization (Figure 2A). Not surpris-
ingly, in NdpKO retinas, VEGF transcripts are present at greatly
increased abundance in the inner nuclear layer (INL), most likely
in Muller glia (Figure 2A). We also localized VEGF-A, VEGF-B,
and class 3 semaphorin binding sites (Nrp1 and Nrp2) in situ
by incubating alkaline phosphatase (AP) fusion proteins with
fresh frozen WT and NdpKO retina sections (Figure 2B). Interest-
ingly, in NdpKO retinas, VEGFR1, VEGFR2, Nrp1, and Nrp2 tran-
script levels are elevated in a spatially heterogeneous manner
within the vascular protrusions from the vitreal surface (arrows
in Figure 2A). Binding sites for VEGF-A and VEGF-B, but not
Sema3F AP fusion proteins, are present throughout the WT reti-
nal vasculature, whereas binding sites for VEGF-A and Sema3F,
but not VEGF-B AP fusion proteins, are present in NdpKO retinal
vasculature (Figures 2B and 2C).
The AP-fusion protein-binding experiments suggest that WT
retinal vasculature displays VEGFR1 (which binds both VEGF-
A and VEGF-B) and possibly VEGFR2 (which binds VEGF-A,
but not VEGF-B), but not detectable Nrp2 (which binds Sema3F
with high affinity) or Nrp1 (which binds Sema3F with lower1334 Cell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc.affinity) (Figure 2C; Geretti et al., 2008;
Pellet-Many et al., 2008). By contrast,
NdpKO retinal vasculature likely displays
VEGFR2, but not VEGFR1 (since AP-
VEGF-A binds, but AP-VEGF-B does
not), as well as Nrp1 and/or Nrp2 (since
AP-Sema3F binds). We suggest that the
VEGFR1 and VEGFR2 in situ hybridiza-
tion signals in NdpKO retinal vasculature
may derive from transcript variants that
code for secreted extracellular VEGF-binding domains (e.g., soluble Flt-1 and its VEGFR2 homolog;
Albuquerque et al., 2009), which would not be detected by AP-
VEGF binding to fresh frozen sections. An increase in Nrp1
and/or Nrp2 inNdpKO retinal vasculature, inferred from the inten-
sity of the in situ hybridization signal, would be predicted to
confer enhanced responsiveness to both class 3 semaphorins
and VEGF. The failure of the NdpKO retinal vasculature to invade
the retina—despite an apparent elevation in the abundance of
tissue-derived VEGF and vascular VEGFR2, as inferred from
the intensity of their in situ hybridization signals—implies a
major role for angiogenesis inhibitors in determining the NdpKO
phenotype.
BBB Integrity and Norrin/Fz4 Signaling
In earlier work,wedescribed the presence of high concentrations
of endogenous immunoglobulin G in the cerebellum and retina in
Fz4/ mice, a likely consequence of defects in BBB and BRB
integrity (Xu et al., 2004; Ye et al., 2009). To extend these obser-
vations to small molecule permeability and to more precisely
localize the sites of BBB/BRB dysfunction, we stained tissue
sections for covalent biotin adducts following intracardiac perfu-
sion of Sulfo-NHS-biotin (molecular weight [MW] = 557 g/mole;
Figure 3. Fz4 Signaling in ECs Is Required
for BBB and BRB Integrity
(A) Intracardiac perfusion with sulfo-NHS-biotin
reveals BBB/BRB defects in cerebellum, olfactory
bulb, spinal cord, and retina, but not cerebral
cortex, in Fz4/ mice. Biotin labeling of liver and
kidney parenchyma serve as a positive control.
Scale bar, 200 mm.
(B) Intracardiac perfusion of Fz4CKOAP/;PDGFB-
CreER mice with sulfo-NHS-biotin shows BBB
defects and PLVAP induction in the molecular
layer of the cerebellum and in the retina (shown in
flat-mount), following early postnatal 4HT. GCL,
granule cell layer; ML, molecular layer. Sulfo-NHS-
biotin leakage at the edge of the cerebellum arises
from the fenestrated vasculature of the choroid
plexus. Scale bar, 100 mm.
(C) Intraperitoneal injection of Evans Blue one day
before sacrifice reveals BBB defects in cerebellum
and olfactory bulb in Fz4CKOAP/;Tie2-Cre mice,
but not in Fz4CKOAP/+;Tie2-Cre controls.
(D) In the adult Fz4CKOAP/;Tie2-Cre cerebellum,
all ECs are AP+ and many molecular layer
and surface ECs are PLVAP+/claudin5. In the
Fz4CKOAP/+;Tie2-Cre cerebellum, all CNS ECs are
PLVAP/claudin5+. Scale bar, 200 mm.
See also Figure S3.Figure 3A). As expected, in both Fz4+/ and Fz4/ mice, exten-
sive biotinylationwasobserved in theparenchymaof the liver and
kidney, organs with fenestrated vasculature. Additionally, in the
Fz4/ CNS, BBB/BRB integrity is compromised in the cere-
bellum, olfactory bulb, spinal cord, and retina, but not in the cere-
bral cortex, striatum, or thalamus (Figure 3A; data not shown).
To delete Fz4 specifically in ECs, we used an Fz4 conditional
knockout allele, in which the Fz4 coding region and 30UTR are
flanked by loxP sites and an AP reporter is located distal to the
30 loxP site (Fz4CKOAP; Ye et al., 2009). When the Fz4CKOAP allele
is placed over a conventional Fz4 null allele (Wang et al., 2001),Cell 151, 1332–1344, DCre-mediated recombination produces
cells that have simultaneously become
Fz4/ and express AP under the control
of the Fz4 promoter. Cre-mediated dele-
tion of Fz4 in ECs—using a Tie2-Cre
transgene or a platelet-derived growth
factor B (PDGFB)-CreER transgene with
postnatal tamoxifen or 4-hydroxytamoxi-
fen (4HT) treatment—led to a loss of
BBB/BRB integrity as assessed by
Sulfo-NHS-biotin perfusion or following
intraperitoneal (IP) injection of Evans
Blue (MW = 961 g/mole) one day prior to
sacrifice (Figures 3B and 3C). Interest-
ingly, BBB disruption in the cerebellum
is largely confined to the molecular layer
(Figure 3B).
A survey of endothelial-specific
markers in Fz4CKOAP/;Tie2-Cre retinal,
cerebellar, spinal cord, and olfactorybulb vasculature showed an increase in the abundance of plas-
malemma vesicle-associated protein (PLVAP), a structural com-
ponent of endothelial fenestrae (Stan et al., 1999), and a reduc-
tion in the abundance of claudin5, a structural component of
EC tight junctions (Figures 3B, 3D, S2B, and S3). These molec-
ular changes in the retinal vasculature were observed as early
as P5 (Figure S2B). The Fz4CKOAP/;Tie2-Cre cerebellar vascula-
ture shows minimal changes in the level of the glucose trans-
porter GLUT1, a marker of brain, but not retina, ECs (Figure 3D).
Although Cre-mediated recombination occurs in all ECs in
Fz4CKOAP/;Tie2-Cre mice, as judged by AP histochemistry (Yeecember 7, 2012 ª2012 Elsevier Inc. 1335
et al., 2009) and AP immunostaining (Figure 3D), in the cere-
bellum, PLVAP+/claudin5 ECs are largely confined to vessels
within and on the surface of the molecular layer (Figure 3D),
consistent with the localized leakage of Sulfo-NHS-biotin (Fig-
ure 3B). In the olfactory bulb, PLVAP+/claudin5 ECs are local-
ized to the glomerular and superficial nerve fiber layers, and in
the cerebral cortex, PLVAP+/claudin5 ECs are confined to
the cortical surface (Figure S3A). These data imply a hitherto
unappreciated molecular heterogeneity among CNS ECs.
Previous work has shown that BBB integrity depends on the
presence of pericytes (Armulik et al., 2010; Bell et al., 2010; Da-
neman et al., 2010), raising the possibility that loss of Norrin/Fz4
signaling in ECs might impair vascular permeability indirectly via
an alteration in pericyte coverage or function or some other
aspect of neurovascular organization. Arguing against this possi-
bility, immunostaining for the pericyte markers PDGF receptor B
in the Fz4CKOAP/;Tie2-Cre cerebellum and NG2 in the mosaic
Fz4CKOAP/;PDGFB-CreER retina (described in detail in the
next section) showed no diminution in pericyte coverage over
Fz4/ ECs (Figures S3C and S3D). Similarly, therewere no alter-
ations in the perivascular basement membrane around Fz4/
ECs in the cerebellum, as determined by immunostaining for
perlecan (HSPG2) or laminin alpha 2 (Figures S3E and S3F),
and there were no alterations in the distribution or abundance
of aquaporin-4 in perivascular astrocyte end-feet (Figure S3B).
Finally, we measured vascular permeability after treatment with
imatinib (Gleevec), a tyrosine kinase inhibitor that blocks CNS
vascular permeability in pericyte-deficient mice by inhibiting
EC transcytosis (Armulik et al., 2010). In these experiments, we
saw no evidence that imatinib decreased vascular permeability
of Sulfo-NHS-biotin leakage (Figure S4). Taken together, these
data argue that the CNS vascular permeability caused by
defects in Norrin/Fz4 signaling is mechanistically distinct from
that caused by loss of pericytes.
Although some or all of these molecular and functional
changes might arise as a direct consequence of loss of Norrin/
Fz4 signaling, the experiments described thus far cannot rule
out the possibility that they might represent secondary
responses to tissue stress. The possibility of such secondary
effects is not implausible, since VEGF signaling is known to
increase vascular permeability and induce endothelial PLVAP
expression (Roberts and Palade, 1995; Strickland et al., 2005).
As described below, we have addressed the question of cell
autonomy versus nonautonomy by creating a genetically mosaic
vasculature.
Genetics Mosaics Define Cell Autonomous Vascular
Defects Resulting from Loss of Fz4 Signaling
To create a Fz4/:Fz4+/ mosaic vasculature in which Fz4/
cells are marked, we treated Fz4CKOAP/;PDGFB-CreER mice
with 4HT postnatally. In the text that follows, all experiments
withFz4CKOAP/;PDGFB-CreERmice include controlFz4CKOAP/+;
PDGFB-CreER littermates and involve 4HT administered
between P4 and P12, most usually 0.1 mg 4HT administered
between P4 and P8. For simplicity, the mice will simply be
referred to by their genotypes, without noting the 4HT treatment
history. In the experiments described below, we show mosaic
vasculature in which Fz4/ ECs are relatively abundant. Iden-1336 Cell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc.tical results were obtained when Fz4/ ECs constitute only
a few percent of the population.
Figure 4A shows genetically mosaic vasculature in the retina
and cerebellum of Fz4CKOAP/;PDGFB-CreERmice treated post-
natally with 4HT. In the retinal vasculature, nearly all Fz4/ ECs
are AP+/PLVAP+/claudin5 and nearly all Fz4+/ ECs are AP/
PLVAP/claudin5+. The principal exceptions are rare Fz4/
ECs that are AP+/PLVAP+/claudin5+. In this experiment,
4HT was delivered at P4, a time prior to the vertical in-growth
of retinal ECs that initiates the formation of the intraretinal
capillary beds. Interestingly, the genetically mosaic retinal vas-
culature exhibits an essentially normal architecture despite the
high fraction of Fz4/ ECs. This observation supports the
idea, initially suggested by Ye et al. (2009), that neighboring
WT ECs can largely correct the vascular migration defects of
Fz4/ ECs.
In Fz4CKOAP/;PDGFB-CreER mice, the immunostaining pat-
tern in the cerebellar vasculature shows a strong anticorrela-
tion between claudin5 and PLVAP expression (Figures 4A and
S5A). The principal exceptions are Fz4/ ECs that are AP+/
PLVAP+/claudin5+ or AP+/PLVAP/claudin5+. Consistent with
the pattern described above for the Fz4CKOAP/;Tie2-Cre cere-
bellum (Figure 3D), the abundance of PLVAP+/claudin5 ECs
is far lower in the granule cell layer than in the molecular layer.
In contrast to molecular layer ECs, many Fz4/ (i.e., AP+) ECs
in the granule cell layer remained PLVAP/claudin5+.
The transcription factor Sox17 is required for normal vascular
development in themouse embryo and in zebrafish (Matsui et al.,
2006; Sakamoto et al., 2007; Pendeville et al., 2008), and in an
earlier study, we observed reduced abundance of Sox17 tran-
scripts in cultured ECs in the absence of Fz4 signaling (Ye
et al., 2009). In mosaic Fz4CKOAP/;PDGFB-CreER cerebellar
and retinal vasculatures, Sox17 is localized to the nuclei of
Fz4+/ ECs, but it is present at reduced abundance and in a
pancellular distribution in Fz4/ ECs (markedwith PLVAP in Fig-
ure 4A, lower right, and Figure 4B, left panels).
Zic3, a second transcription factor that shows reduced
transcript abundance in cultured ECs in the absence of Fz4
signaling, is undetectable in Fz4/ retinal ECs (marked with
PLVAP; Figure 4B, right panels). Interestingly, immunostaining
of WT retinas showed that Zic3 is normally expressed in veins
and capillaries, but not arteries (Figure 4B), suggesting that
Fz4/ vein and capillary ECs may have adopted a more arterial
fate. This interpretation is consistent with the idea that the retinal
artery/vein-crossing phenotype associated with a loss of Norrin/
Fz4 signaling (Figures 1B, S1, and S2A) may reflect a failure to
fully distinguish artery and vein identities.
We have also examined the cell autonomy of the two features
of EC receptor composition that distinguish WT retinal vascula-
ture from retinal vasculature that lacks Norrin/Fz4 signaling:
loss of VEGF-B binding sites and acquisition of Sema3F binding
sites (Figure 2B). As seen in Figure 4C, both attributes are cell
autonomous properties of the Fz4/ state.
Fz4 Signaling and the Plasticity of the Endothelial
Barrier Phenotype
In contrast to the retina, Norrin/Fz4 signaling in the brain plays
little or no role in the development of vascular architecture (Xu
Figure 4. EC-Specific Genetic Mosaics
Define Cell-Autonomous Molecular Defects
(A) Mosaic vasculature in Fz4CKOAP/;PDGFB-
CreER mice treated with 4HT between P4 and
P8. Anti-AP immunostaining (red; top two rows)
marks Fz4/ cells. In retina (top row), almost all
AP+ ECs are PLVAP+/claudin5. In cerebellum
(lower three rows), most AP+ ECs in the molecular
layer are PLVAP+/claudin5 and show reduced
GLUT1. The second row shows examples of
minority AP+ EC phenotypes: PLVAP+/claudin5+
(white arrow) and PLVAP/claudin5+ (yellow
arrow). Sox17 is nuclear in Fz4+/ ECs (red arrows;
enlarged regions, lower right panels), but is
uniformly distributed at a low level in many Fz4/
ECs (white arrow). ML, molecular layer; GCL,
granule cell layer. Colored squares show the
colors in each panel. Scale bars, 100 mm.
(B) In mosaic retinas, Sox17 in Fz4/ ECs
switches localization from nuclear (red arrow; left
panels) to pancellular (white arrow), and Zic3 is lost
(white arrows, right panels). PLVAP marks Fz4/
cells. A, artery; V, vein. Scale bars, 100 mm.
(C) In mosaic retinas, Fz4/ ECs show a cell
autonomous loss of AP-VEGF-B binding sites
(green ECs in left panel) and acquisition of AP-
Sema3F binding sites (red ECs in right panel).
Scale bar, 100 mm.et al., 2004; Luhmann et al., 2008; Ye et al., 2009). However, the
requirement for Fz4 signaling in promoting the PLVAP/clau-
din5+ BBB+ state in cerebellum, spinal cord, and olfactory
bulb indicates that Norrin and/or Wnts activate Fz4 in brain
ECs, a plausible idea, given that Fz4 is expressed in virtually all
ECs and Ndp is expressed by glia throughout the CNS (Ye
et al., 2009, 2011). To define the role of Norrin in this process,
we examined BBB integrity and the expression of vascular
markers in the NdpKO CNS. In the NdpKO cerebellum, 5% ofCell 151, 1332–1344, Dmolecular layer ECs exhibit a conversion
from a PLVAP/claudin5+ state to a
PLVAP+/claudin5 state (Figure 5A).
These PLVAP+/claudin5 ECs also
show reduced levels of occludin and
GLUT1 and are associated with local
disruptions of BBB integrity, as deter-
mined by Sulfo-NHS-biotin leakage
(Figures 5A, 5B, and S5B). As described
above for the Fz4/:Fz4+/ mosaic vas-
culature, the conversion to a PLVAP+/
claudin5/BBB state appears to occur
far more readily in the molecular layer
than in the granule cell layer (Figures 5A
and 5B). The most striking aspect of
this phenotype is its bimodality. In the
NdpKO cerebellum, ECs are observed in
either of two mutually exclusive states of
gene expression and Norrin/Fz4 signaling
appears to determine the relative proba-
bility that an EC will exist in one or the
other state.In all of the experiments described thus far, loss of Norrin or
Fz4 began early in embryonic or postnatal life, thereby en-
compassing most or all of the periods when the retinal and cere-
bellar vasculatures are developing. Figure 5C shows that, when
Fz4 deletion is induced during adulthood, a conversion from a
PLVAP to a PLVAP+molecular phenotype occurs, with a corre-
sponding loss of local BBB/BRB integrity. Thus, ongoing Fz4 sig-
naling in mature ECs is required to maintain the BBB/BRB state.
This interpretation is further supported by recent experiments, inecember 7, 2012 ª2012 Elsevier Inc. 1337
Figure 5. Norrin/Fz4 Signaling Controls
BBB Plasticity, and in Mosaic Retinas,
Fz4/ ECs Are Slowly Eliminated
(A) In the adult NdpKO cerebellum, a subset of ECs
in the molecular layer are PLVAP+/claudin5/
occludin (white arrows). In (A) and (B), colored
squares show the colors in each panel. Scale bar,
100 mm.
(B) Sites of BBB deficiency in the NdpKO cere-
bellum coincide with PLVAP+ ECs. See also
Figures S4 and S5. ML, molecular layer; GCL,
granule cell layer. Scale bar, 200 mm.
(C) Adult conversion of ECs from Fz4+/ to Fz4/
leads to induction of PLVAP and colocalized
BBB breakdown. The diagram shows sparse Cre-
mediated conversion of ECs from Fz4+/ to
Fz4/. Scale bar, 200 mm.
(D) Restoration of Norrin expression in the adult
NdpKO cerebellum restores the BBB. Six 9- to 12-
week-old NdpKO;Z/Norrin;GLAST-CreER mice,
treated >3 weeks before sacrifice with 3 3 5 mg
oral tamoxifen, have a largely intactBBB (right), but
six littermate control NdpKO mice (lacking either
Z/Norrin orGLAST-CreER or both) sacrificed at the
same age show patchy BBB breakdown (left).
Untreated NdpKO;Z/Norrin;GLAST-CreER mice
and NdpKO mice treated with tamoxifen or with
vehicle (sunflower seed oil) alone show cerebellar
leakage indistinguishable from NdpKO mice.
(E) Progressive loss of Fz4/ ECs in mosaic
Fz4/:Fz4+/ retinal vasculature. Fz4CKOAP/;
PDGFB-CreER mice were exposed to 4HT at P4,
one eyewas enucleated atP18 and the other eye
atP50, and retina immunostained for PLVAP and
claudin5. Left: left and right retinas from the same
mouse, harvested at P18 and P50, respectively.
Center, the ratio of PLVAP+ to claudin5+ vascu-
lature in the OPL declines over time. Data points
derived from the two retinas of the samemouse are
connected by a line. Right: density of adult (P53–
P80) OPL vasculature in retinas from Fz4CKOAP/;
PDGFB-CreER and Fz4CKOAP/+;PDGFB-CreER
littermates that had received 0.1 mg 4HT between
P5 and P12 (mean ± SD). Scale bar, 500 mm.
(F) Cell proliferation in OPL vasculature from
nine pairs of Fz4CKOAP/;PDGFB-CreER and
Fz4CKOAP/+;PDGFB-CreER littermates following
0.1 mg 4HT treatment between P5 and P12 and
EdU injections every 2 or 3 days from P21–P25 to
P43–P56. Retinas were harvested between P53
and P80. Left: four panels from the retina with the
highest level of EdU labeling showing EdU+ nuclei
on/within vessels (yellow arrows), adjacent to
vessels (red arrows), or far from vessels (white
arrows). Center: number of EdU+ nuclei on, near,
or far from Fz4/ and Fz4+/ ECs in territories of
1 mm2; right: the same data, but individually
normalized to the densities of Fz4/ and Fz4+/
ECs within each territory. Scale bar, 100 mm.
See also Figures S4, S5, and S7.which IP injection of a function-blocking anti-Fz4 monoclonal
antibody (mAb) led to a compromised BRB (Paes et al., 2011).
We next asked whether the reciprocal phenotypic conversion
is possible: that is, whether PLVAP+/claudin5/BBB ECs can
convert to a PLVAP/claudin5+/BBB+ state. To address this1338 Cell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc.question, we used a GLAST-CreER bacterial artificial chromo-
some (BAC) transgene (P.M.S., A.R., and J.N., unpublished
data) that drives recombination in many CNS glia—including
Muller glia in the retina and Bergmann glia in the cerebellum,
the normal cellular sources of CNS Norrin (Ye et al., 2011)—to
activate Norrin expression from a cytomegalovirus-actin (CAG)
promoter LoxP-stop-LoxP Norrin knockin allele at the Ubiqui-
tin-B locus (referred to as Z/Norrin; Ye et al., 2009). As seen for
six NdpKO;Z/Norrin;GLAST-CreER mice and six NdpKO control
mice shown in Figure 5D, activating Norrin production in adult-
hood efficiently converted the patchy BBB– NdpKO vasculature
to an almost completely BBB+ state. These data show that, in
fullymature ECs, theBBB+ state can be lost following a decrease
in Fz4 signaling or acquired following an increase in Fz4
signaling.
The BBB rescue shown in Figure 5D most likely reflects a Nor-
rin-dependent conversion of pre-existing cerebellar ECs from
a PLVAP+/claudin5/BBB to PLVAP/claudin5+/BBB+ state.
An alternative possibility is that the PLVAP+/claudin5 ECswere
replaced by PLVAP/claudin5+ ECs.We have attempted to look
for evidence of such replacement in 3- or 4-week-old tamoxifen-
treated NdpKO;Z/Norrin;GLAST-CreER mice by EdU labeling. In
this experiment, oral tamoxifen delivery on experimental days 1,
3, and 5 was observed to largely restore BBB integrity by day 12.
We therefore labeled with EdU on day 6, a time when the vascu-
lature is presumably converting from a BBB to a BBB+ state,
and sacrificed the mice one day later. Examination of >1 mm3
of cerebellar tissue from each of two such mice showed no
EdU incorporation into any vascular cells (data not shown), sug-
gesting that replacement of PLVAP+/claudin5/BBB ECs by
newly postmitotic PLVAP/claudin5+/BBB+ ECs is an unlikely
scenario.
ECs Deficient in Norrin/Fz4 Signaling Are Slowly Lost
In the course of examining large numbers of mosaic retinas from
Fz4CKOAP/;PDGFB-CreERmice that had been treated with 4HT
during early postnatal life, we noticed that the number of Fz4/
ECs, as revealed by staining for PLVAP, appeared to decline with
age. To quantify this observation, Fz4CKOAP/;PDGFB-CreER
mice were treated with 4HT at P4, one eye was removed at the
time of retinal vascular maturation (P15–P20), and the other
eye was removed more than one month later (P50–P70). Each
retina was stained for claudin5, PLVAP, and AP, and the ratio
of PLVAP+ to claudin5+ vasculature was quantified in flat-mount
images of the entire retina at the level of the OPL (Figure 5E, left).
In Fz4CKOAP/;PDGFB-CreER retinas, the correlation between
PLVAP+ and AP+ ECs is very nearly perfect (Figure 4A). There-
fore, in the present experiment, we have used PLVAP rather
than AP to quantify Fz4/ ECs, since PLVAP can be visualized
with a higher signal-to-noise ratio than can AP. As seen in Fig-
ure 5E center, the ratio of PLVAP+/claudin5 to PLVAP/clau-
din5+ ECs declined with age in all six mice examined. Accompa-
nying the selective loss of PLVAP+/claudin5 ECs is an overall
lower vascular density in adult mosaic Fz4CKOAP/;PDGFB-
CreER retinas compared to their Fz4CKOAP/+;PDGFB-CreER
littermates (Figure 5E, right).
An analogous decline in vascular density occurs in the
Fz4CKOAP/;Tie2-Cre cerebellum, as seen by comparing
Fz4CKOAP/;Tie2-Cre and Fz4CKOAP/+;Tie2-Cre cerebellar sec-
tions in Figures S3C, S3E, and S3F. A much more modest loss
of vascular density was noted previously in NdpKO cerebella
(Luhmann et al., 2008). While these results are consistent with
a cell autonomous mechanism for EC loss, the progressive cere-bellar degeneration associated with loss of Fz4 signaling in the
vasculature leaves open the possibility that nonautonomous
effects from the cerebellar parenchyma could drive vascular
pruning (Wang et al., 2001). By contrast, the genetic mosaic
analysis of retinal vasculature (described in the preceding para-
graph) is unaffected by this ambiguity, as it involves a compar-
ison of Fz4+/ and Fz4/ ECs within the same tissue and in
the absence of retinal degeneration.
To determine whether the progressive loss of Fz4/ ECs in
themosaic retina is associatedwith EC proliferation, Fz4CKOAP/;
PDGFB-CreER and control Fz4CKOAP/+PDGFB-CreER litter-
mates were injected with EdU every 2 or 3 days between P23
andP50 and the retinas examined 1 or 2weeks later (Figure 5F).
Within the OPL, Fz4CKOAP/;PDGFB-CreER and Fz4CKOAP/
+PDGFB-CreER retinas have on average 25+/21 and 8+/7
EdU+ nuclei per mm2, respectively, a significant difference (p =
0.01). Interestingly, when EdU counts were normalized to the
density of Fz4/ and Fz4+/ ECs (identified by immunostaining),
it was found that EdU+ nuclei were substantially enriched on or
adjacent to Fz4/ ECs (Figure 5F, right panels) and that this
density of EdU+ nuclei was significantly higher than the densities
associated with Fz4+/ ECs in both Fz4CKOAP/;PDGFB-CreER
and Fz4CKOAP/+PDGFB-CreER retinas. Figure 5F also shows
that the density of EdU+ nuclei associated with Fz4+/ vascula-
ture was modestly elevated in Fz4CKOAP/;PDGFB-CreER com-
pared to Fz4CKOAP/+PDGFB-CreER retinas. These data indicate
that, during the process of eliminating Fz4/ ECs, there is a
low but detectable level of proliferation among vessel-associ-
ated cells, most likely ECs and pericytes. However, the overall
conclusion is that newly generated ECsmake, at most, amodest
contribution to vascular remodeling in the adult Fz4CKOAP/;Tie2-
Cre retina, and that vascular remodeling consists largely of a
selective removal of Fz4/ ECs.
Modifying Retinal Vascular Development by Controlling
the Timing of Norrin Production
To explore the vascular response to Norrin/Fz4 signaling at early
times in development, we determined the consequences of
precocious Norrin/Fz4 signaling using Z/Norrin;Foxg1-Cre mice
(Figure 6). Foxg1-Cre activates target gene expression in the
anterior retina by embryonic day (E)10 (He´bert and McConnell,
2000), an observation that we have confirmed by crossing
Foxg1-Cre to Z/H2B-GFP, a knockin that is identical to Z/Norrin,
except for the identity of the reporter (Figure 6C). By contrast, the
endogenous Ndp gene is only expressed in the retina beginning
late in gestation. Prenatal Ndp expression is confined to a region
immediately adjacent to the optic disc; postnatally, Ndp is ex-
pressed in developing Muller glia throughout the retina (Ye
et al., 2009, 2011). Figure 6 shows that prenatal activation of
the Z/Norrin locus leads to precocious vascular invasion of the
retina from the adjacent hyaloid vessels (i.e., vessels residing
in the vitreous). Overall, 28/30 Foxg1-Cre;Z/Norrin eyes and
0/36 control eyes harvested between E17 and P0 exhibited
vascular invasion into the retina (p = 1.3 3 1016; controls
comprised littermates that lacked Foxg1-Cre and/or Z/Norrin).
In Z/Norrin;Foxg1-Cre eyes, the invading vasculature was con-
fined to the anterior retina, corresponding to the territory with
Cre-mediated recombination.Cell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc. 1339
Figure 6. Early Production of Norrin Induces Precocious Vascular
Invasion of the Retina
(A) Retina flat-mounts at E17 show extensive intravitreal (hyaloid) vasculature
with intraretinal sprouts in the Z/Norrin;Foxg1-Cre retina (right), but not in the
WT littermate retina (left). Scale bar, 100 mm.
(B) At E17, there is a vascular sprout (arrow) in the Z/Norrin;Foxg1-Cre retina
(right), but not in the littermate control retina (left). The GS-lectin-stained lens is
at center right.
(C) By P1, the Foxg1-Cre transgene has recombined the Z/H2B-GFP reporter
in the anterior retina and lens. A, anterior; P, posterior. White arrow, boundary
between recombined and nonrecombined retinal zones.
(D) E17 Z/Norrin;Foxg1-Cre retina at higher magnification showing a vascular
sprout (arrows) emerging from the hyaloid vasculature (top) and projecting into
the retina. Scale bar, 100 mm.To explore the role of Norrin/Fz4 signaling at later stages, we
used 4HT (delivered over 3–5 days by three IP injections of
200 mg each) to activate Norrin expression in Muller glia in
NdpKO;Z/Norrin;GLAST-CreER mice beginning from P4 to P23,
and then we assessed image-forming visual function in adult-
hood by the optokinetic response (OKR; Cahill and Nathans,
2008) and quantified retinal vascular architecture (Figure 7).
The OKR depends on transmission of rod and cone signals to
retinal ganglion cells via interneurons in the INL. In NdpKO and
Fz4/ mice, the OKR is absent, presumably because these
interneurons, although present, are insufficiently supplied with
oxygen and nutrients (Ye et al., 2009). In disorders characterized
by incomplete intraretinal vascularization, the INL is the most
vulnerable of the three retinal layers, as it cannot be efficiently1340 Cell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc.supplied by either the choroidal circulation, which supplies the
photoreceptors, or the vasculature at the vitreal surface, which
supplies the ganglion cell layer. INL hypoxia can be readily
demonstrated by visualizing the distribution of pimonidazole
(Hypoxyprobe) adducts in the adult NdpKO retina (Figure S6). In
the present experiments, a comparison of the OKR among
30 4HT-treated NdpKO;Z/Norrin;GLAST-CreER mice showed
a bimodal distribution (Figure 7C, left), implying that the depen-
dence of retinal interneuron function on vascular development
exhibits a sharp threshold. 4HT injection on or before P8 leads
to rescue of the OKR in 50% of mice, but 4HT injection after
P8 fails to rescue (Figure 7C, right).
Following OKR testing, the retinal vasculature from 19
NdpKO;Z/Norrin;GLAST-CreER mice was analyzed (Figure 7D).
The vitreal surface, IPL, and OPL vascular beds were color
coded, and the area occupied by the vasculature was quantified
for each (Figures 7B and 7E). An example of a retina with an IPL
vascular bed, but no OPL vascular bed is seen in Figure 7A
(mouse 4420). In some cases, graded differences in vasculariza-
tion were observed across a single retina (e.g., mice 4424 and
4576 in Figures 7A and 7B). As seen in Figure 7E, several trends
emerge from this data: (1) earlier 4HT treatment produces
greater intraretinal vascular coverage, (2) the IPL vasculature is
rescued more efficiently than the OPL vasculature, and (3) lower
vascular density within the retina (i.e., in the IPL and OPL) is
associated with higher vascular density on the vitreal surface,
an effect that is probably driven by retinal hypoxia. The second
trend could reflect the greater distance from the vitreal face of
the retina—from which the intraretinal vasculature originates—
to the OPL compared to the IPL. However, we think it more likely
reflects the earlier development of the OPL vasculature
compared to the IPL vasculature. In particular, we imagine that
there may be a distinct time window, during which the retina
permits OPL or IPL invasion.
A less interesting explanation for the inability of later 4HT injec-
tions to rescue the NdpKO phenotype is an age-dependent
decline in the efficiency of Cre-mediated recombination at
the Z/Norrin locus. To test this possibility, we treated Z/H2B-
GFP;GLAST-CreER mice with 4HT in the same manner as the
NdpKO;Z/Norrin;GLAST-CreER mice and counted the number
of GFP+ Muller glial nuclei per retina in adulthood. 4HT injection
starting at P5, P8, and P10 produced, on average, 3,085, 2,060,
and1,880GFP+nuclei per retina (n= 2or 3 retinas per timepoint).
It seems unlikely that this modest difference in the efficiency of
Cre-mediated recombination could account formore thanasmall
fraction of the time-dependent decline in phenotypic rescue.
Taken together, the experiments in Figures 6 and 7 indicate
that the retinal vasculature is responsive to Norrin/Fz4 signaling
throughout its development. More generally, these experiments
illustrate the profound effect that small changes in the timing
of ligand-receptor signaling can have on the architecture of a
vascular network.
DISCUSSION
Together with earlier work, the experiments reported here show
that Norrin/Fz4 signaling regulates multiple aspects of retinal
vascular development, including EC proliferation, migration,
and invasion, and arterial and venous identity and topography.
By creating mosaic Fz4/:Fz4+/ retinal and brain vasculatures,
we show that Frizzled4 signaling in ECs controls a cell autono-
mous developmental program that is essential for BBB/BRB
integrity and regulates the expression of transcription factors,
cell surface receptors, and cell junction proteins. With gain or
loss of Fz4 signaling in mature vasculature, this program can
be activated or silenced, respectively. These observations imply
that the BBB/BRB state remains plastic throughout life and that
continuous Frizzled signaling is required for its maintenance.
In contrast to the cell autonomy of the BBB/BRB phenotype,
the developing Fz4/:Fz4+/mosaic retinal vasculature exhibits
nonautonomous rescue of vascular network formation, indi-
cating that angiogenesis is a social process in which information
is distributed across the EC population. Finally, we observe that
Fz4/ ECs are selectively eliminated from the Fz4/:Fz4+/
mosaic retinal vasculature, implying the existence of a vascular
quality control program.
The Role of Frizzled Signaling in Vascular Diversity and
Plasticity
Although Fz4 is expressed throughout the CNS and non-CNS
vasculature, the Fz4/ phenotype differs dramatically in dif-
ferent CNS regions. In the interior of the cerebral cortex, thal-
amus, and striatum, there is no apparent phenotype. In the spinal
cord, nerve fiber and glomerular layers of the olfactory bulb,
molecular layer of the cerebellum, and at the surface of the cere-
bral cortex, there is a loss of BBB integrity and a variable switch
of ECs to a PLVAP+/claudin5 state, with little or no effect on
development of vascular architecture. By contrast, in the retina,
there are multiple developmental defects—including a failure to
form intraretinal capillary beds and excessive artery/vein cross-
ings—accompanied by a loss of BRB integrity and a complete
switch to a PLVAP+/claudin5 state. We note that the primary
nature of the retinal EC switch to a PLVAP+/claudin5 state
was only revealed by studying Fz4/:Fz4+/ mosaics, because
the severe stunting of vascular development in Fz4/ and
NdpKO retinas leads to tissue hypoxia and compensatory neo-
vascularization that preclude a clear distinction between primary
and secondary phenotypic changes at the cellular level.
Ndp is expressed by glia throughout the CNS (Ye et al., 2011),
but the NdpKO phenotype, like the Fz4/ phenotype, varies in
different CNS regions. In the cerebral cortex, thalamus, and
striatum, there is no apparent phenotype. In the nerve fiber layer
of the olfactory bulb and the molecular layer of the cerebellum,
there is a loss of BBB integrity, but only a small minority of ECs
switch to a PLVAP+/claudin5/BBB state. By contrast, in the
retina, the phenotype is uniform, severe, and indistinguishable
from the Fz4/ phenotype. Perhaps the most surprising aspect
of theNdpKO and Fz4KO phenotypes in the cerebellum and olfac-
tory bulb are their cellular heterogeneity: Norrin/Fz4 andWnt/Fz4
signaling appears to act by biasing a cell-autonomous choice
between distinct developmental states, with the result that adja-
cent and genetically identical ECs can exhibit strikingly different
molecular phenotypes.
These findings—together with reports by others on the vas-
cular consequences of gain or loss of Wnt7a, Wnt7b, and
beta-catenin function and of administration of anti-Fz4 mAb(Liebner et al., 2008; Stenman et al., 2008; Daneman et al.,
2009; Paes et al., 2011)—are consistent with the following model
(Figure S7): (1) all CNS ECs require canonical Wnt signaling to
develop and maintain a BBB/BRB competent state; (2) in retinal
ECs, this signaling pathway is activated exclusively by Norrin
and Fz4; (3) in the nerve fiber and glomerular layers of the olfac-
tory bulb, the molecular layer of the cerebellum, the most super-
ficial layer of the cerebral cortex, and the spinal cord, Norrin and/
or one or more Wnt ligands activate this pathway primarily
through Fz4; (4) in other brain regions, additional Frizzled or
non-Frizzled receptors and their Wnt ligands are fully redundant
with Norrin and Fz4, and (5) when canonical Wnt signaling
declines below a threshold level, the phenotypic response tends
to be quantized rather than graded, and is manifested by an
increase in the probability that ECs will switch from a PLVAP/
claudin5+/BBB+ to a PLVAP+/claudin5/BBB state.
Frizzled Signaling and Vascular Architecture
The vascular defects reported in theWnt7a/;Wnt7b/ neural
tube at E10–E12 (Stenman et al., 2008; Daneman et al., 2009)
bear a striking resemblance to NdpKO and Fz4/ defects in
the retina: in both cases, surface vessels penetrate only a small
distance into the target neural tissue. In the NdpKO retina, these
abortive vascular protrusions persist throughout the life of the
mouse and high levels of retina-derived VEGF are unable to stim-
ulate further in-growth, although ECs on the retinal surface are
induced to proliferate. These data suggest that, if target-derived
proangiogenic signaling drives vascular invasion into the CNS,
then canonical Wnt and Norrin signaling act to gate that process.
The selective decrease in OPL capillaries in NdpKO;Z/Norrin;
GLAST-CreER retinas that experienced late Norrin expression
suggests an additional constraint on vascular growth: a time-
dependent switch of retinal tissue from a permissive to a refrac-
tory state. In this case, the data suggest that the OPL is permis-
sive for vascular invasion in early postnatal life and then converts
to a more refractory state, whereas the IPL retains a permissive
character at later times. If this model is correct, it will be inter-
esting to identify the signalingmolecules responsible for this inhi-
bition. These or related molecules might also function to selec-
tively exclude larger vessels from traversing regions of retina
specialized for high acuity vision, such as the primate fovea.
Clinical Implications of Frizzled Signaling and BBB/BRB
Integrity
Loss of BBB/BRB integrity has been recognized in a wide variety
of clinical contexts, including stroke, inflammatory and infectious
diseases, diabetes, and traumatic brain injury (Ballabh et al.,
2004). Strong evidence that pathologically increased vascular
permeability plays a central role in a variety of ophthalmic
disorders—including age-related macular degeneration and dia-
betic macular edema—comes from the rapid improvement in
visual function produced by intraocular injection of anti-VEGF
drugs (Truong et al., 2011). The rapid response arises from
a decrease in vascular permeability and a concomitant decrease
in retinal edema. Controlling edema is also central to the
management of stroke and traumatic brain injury (Walcott
et al., 2012), and the difference in permeability between tumor-
associated and nontumor vasculature is being exploited inCell 151, 1332–1344, December 7, 2012 ª2012 Elsevier Inc. 1341
Figure 7. Initiating Norrin Production at Different Times during Retinal Vascular Development Leads to Graded Rescue of the NdpKO
Phenotype
(A) Adult retina cross-sections show capillaries in the IPL and OPL in WT, a sparse IPL capillary network in NdpKO;Z/Norrin;GLAST-CreERmice treated with 33
0.2 mg 4HT over 3 days starting at P4 (mouse 4424) or P5 (mouse 4420), and a greatly reduced (4424) or absent (4420) OPL capillary network. In all cases, Norrin
production restored claudin5. See also Figure S6. White arrowheads, normal locations of the three vascular layers. Scale bar, 100 mm.
(B) Adult retina flat-mounts stained with GS-lectin with the vertical position of the vasculature color-coded. NdpKO;Z/Norrin;GLAST-CreERmice treated with 33
0.2 mg 4HT over 3 days starting at P4 (mouse 4424) or P8 (mouse 4576) exhibit sparser IPL and OPL capillary networks. Scale bar, 100 mm.
(C) Visual function among adult NdpKO;Z/Norrin;GLAST-CreER mice measured by OKR. Left: 90 s OKR traces in response to 30 s of rotating black and white
vertical stripes sandwiched between 30 s rest periods. Mouse 4420 shows a normal OKR;mouse 4426 shows only spontaneous eyemovements. Right: summary
of OKR testing.
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neuroimaging and neuro-oncology (Eichler et al., 2011). Finally,
the accessibility of the CNS parenchyma to systemically admin-
istered drugs is determined largely by the BBB/BRB, and there-
fore, variability in barrier function is of broad interest in clinical
pharmacology (de Boer and Gaillard, 2007). The central role of
Frizzled signaling in BBB/BRB development and maintenance
implies that naturally occurring or induced variations in this
signaling pathway will be of clinical interest.
EXPERIMENTAL PROCEDURES
Mice
The following mouse alleles were used: Fz4 (Wang et al., 2001); Fz4CKOAP,
Ndp, Z/Norrin (Ye et al., 2009); PDGFB-CreER (Claxton et al., 2008), Tie2-
Cre (Kisanuki et al., 2001), Foxg1-Cre (He´bert and McConnell, 2000);
GLAST-CreER (a BAC transgenic line that has CreER inserted at the initiator
methionine codon of the GLAST transporter gene); and Z/H2B-GFP (a LoxP-
stop-LoxP knockin at the Ubb locus).
Histochemistry and Immunohistochemistry
Sources of antibodies and experimental procedures related to histochemistry,
immunohistochemistry, in situ hybridization, and EdU and Hypoxyprobe
labeling are described in Supplemental Information.
BBB and BRB Integrity
For Sulfo-NHS-LC-Biotin perfusion, deeply anesthetized mice were perfused
with 10–15 ml 0.5 mg/ml Sulfo-NHS-LC-Biotin (Thermo Scientific 21335) in
PBS, followed by 1% paraformaldehyde (PFA) in PBS. Eyes were postfixed
in 1% PFA at 4C for 4–6 hr prior to retina dissection. Whole mount retinas
and 100 mm vibratome sections of cerebella were incubated in Texas Red
Streptavidin (Vector SA-5006) diluted in PBS + 0.5% Triton + 0.1mM CaCl2
(PBSTC) + 10%normal goat or donkey serum, washed in PBSTC andmounted
in Fluoromount G. For Evans Blue leakage, 100 ml of 2% Evans Blue (Sigma
E-2129) was injected IP 24 hr prior to perfusion with 4% PFA in PBS. Brains
were dissected and photographed intact.
Quantification of Retinal Vascular Coverage and EdU+ Nuclei
For the NdpKO;Z/Norrin;GLAST-CreER experiments, four Z-stacks covering
1.44 mm2 and offset approximately 0.3 mm from the optic disc were captured
from each Griffonia simplicifolia (GS)-lectin-stained retina using a Zeiss
LSM700 microscope. For each of the three retinal vascular beds, the fraction
of the X-Y plane occupied by fluorescent GS-lectin was measured using
ImageJ. For the analysis of Fz4/ EC coverage in retinas from Fz4CKOAP/;
PDGFB-CreER mice, the ratio of PLVAP+ to claudin5+ vascular coverage in
the OPL was quantified using ImageJ. For quantifying OPL vascular coverage
and EdU+ nuclei, territories of 1 mm2 were analyzed. Parallel lines spaced at
100 mm intervals were overlayed on the image and the number of crossings
of Fz4+/ and Fz4/ vessels were counted. EdU+ nuclei within each territory
were categorized as residing on a vessel, adjacent to a vessel, or not near
a vessel. Counts of EdU+ nuclei on or near vessels were normalized to the rela-
tive densities of the vessels of that genotype.
Alkaline Phosphatase Fusion Protein Binding
Human VEGF-A 165 or human VEGF-B 186 coding regions without their signal
peptides were cloned 30 of an AP coding region with a C-terminal triple-myc
tag. The AP-Sema3F plasmid was a gift from Alex Kolodkin. Conditioned
media containing the AP fusion proteins were collected from transiently trans-
fected 293 cells and stored at 4C. Fresh frozen retina sections were blocked(D) Red boxes show regions of adult retina flat-mounts displayed in (B) and quan
(E) Summary of 4HT injection times, adult retinal vascular coverage, and OKR in
regions were imaged as shown in (C) and (D), and the fraction of the X-Y plane at
was determined.
See also Figure S6.in Dulbecco’s modified Eagle’s medium (DMEM)/F12 containing 10% fetal
bovine serum, with or without competitor VEGF peptide (Sigma V4512,
10 mg/ml), for 1 hr at 4C and then incubated with conditioned medium, with
or without competitor, for 1 hr at 4C. The sections were then washed six times
with cold DMEM/F12, fixed with 4% PFA for 15 min, and incubated at 65C for
90 min. AP activity was detected with 5-bromo-4-chloro-3-indolyl-phosphate/
nitro blue tetrazolium and blood vessels were visualized by staining with Alexa
fluor 594 conjugated GS lectin.Imatinib Treatment
Two-month-old Fz4CKOAP/;Tie2-Cremice were injected intraperitoneally with
Imatinib (LC Laboratories) at a dose of 150 mg/kg. Two hours later, the mice
were perfused with 0.5 mg/ml Sulfo-NHS-biotin followed by 2% PFA.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2012.10.042.ACKNOWLEDGMENTS
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